Cargando…

Preventive therapy with galcanezumab for two consecutive cluster bouts in patients with episodic cluster headache: an observational multicenter study

BACKGROUND: Cluster headache is a severe and disabling primary headache disorder. Galcanezumab is a monoclonal antibody against calcitonin gene-related peptide and a preventive therapy for episodic cluster headache. However, the approval and insurance coverage for episodic cluster headache differ in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Yooha, Kang, Mi-Kyoung, Moon, Heui-Soo, Kim, Byung-Kun, Cho, Soo-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566025/ https://www.ncbi.nlm.nih.gov/pubmed/37817084 http://dx.doi.org/10.1186/s10194-023-01661-7

Ejemplares similares

Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache
por: Mo, Heejung, et al.
Publicado: (2022)

Reducing Episodic Cluster Headaches: Focus on Galcanezumab
por: Pellesi, Lanfranco, et al.
Publicado: (2020)

Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment
por: Láinez, Miguel J. A., et al.
Publicado: (2021)

Development and Validation of the Cluster Headache Screening Questionnaire
por: Chung, Pil-Wook, et al.
Publicado: (2019)

Clinical Features of Probable Cluster Headache: A Prospective, Cross-Sectional Multicenter Study
por: Sohn, Jong-Hee, et al.
Publicado: (2018)

Smoking History and Clinical Features of Cluster Headache: Results from the Korean Cluster Headache Registry
por: Chung, Pil-Wook, et al.
Publicado: (2021)

Clinical Features of Cluster Headache Patients in Korea
por: Moon, Heui-Soo, et al.
Publicado: (2017)

Clinical factors influencing the impact of cluster headache from a prospective multicenter study
por: Sohn, Jong-Hee, et al.
Publicado: (2020)

Impact of cluster headache on employment status and job burden: a prospective cross-sectional multicenter study
por: Choi, Yun-Ju, et al.
Publicado: (2018)

Diagnostic Delay and Its Predictors in Cluster Headache
por: Kim, Byung-Su, et al.
Publicado: (2022)

Differences in Characteristics and Comorbidity of Cluster Headache According to the Presence of Migraine
por: Song, Tae-Jin, et al.
Publicado: (2019)

Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial
por: Kim, Byung-Kun, et al.
Publicado: (2023)

The impact of remission and coexisting migraine on anxiety and depression in cluster headache
por: Kim, Byung-Su, et al.
Publicado: (2020)

Chronic Daily Headache and Medication Overuse Headache in First-Visit Headache Patients in Korea: A Multicenter Clinic-Based Study
por: Cha, Myoung-Jin, et al.
Publicado: (2016)

Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases
por: Kashiwagi, Kenta, et al.
Publicado: (2023)

Clinical features of chronic cluster headache based on the third edition of the International Classification of Headache Disorders: A prospective multicentre study
por: Cho, Soo-Jin, et al.
Publicado: (2019)

Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache
por: Kudrow, David, et al.
Publicado: (2020)

Associated Factors and Clinical Implication of Cutaneous Allodynia in Patients with Cluster Headache: A Prospective Multicentre Study
por: Kim, Byung-Su, et al.
Publicado: (2019)

Clinical features of cluster headache without cranial autonomic symptoms: results from a prospective multicentre study
por: Chu, Min Kyung, et al.
Publicado: (2021)

Cortical plasticity in episodic and chronic cluster headache
por: Naegel, Steffen, et al.
Publicado: (2014)

Corrigendum: Impairment in episodic and chronic cluster headache
Publicado: (2011)

Therapy for Psychiatric Comorbidities in Patients with Episodic Cluster Headache: A Prospective Multicenter Study
por: Liu, Qinlin, et al.
Publicado: (2022)

Different doses of galcanezumab versus placebo in patients with migraine and cluster headache: a meta-analysis of randomized controlled trials
por: Yang, Yanbo, et al.
Publicado: (2020)

Oxygen Therapy in Cluster Headache, Migraine, and Other Headache Disorders
por: Mo, Heejung, et al.
Publicado: (2022)

Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache
por: Andrews, J Scott, et al.
Publicado: (2021)

The Neuropsychology of Cluster Headache: Cognition, Mood, Disability, and Quality of Life of Patients With Chronic and Episodic Cluster Headache
por: Torkamani, Mariam, et al.
Publicado: (2015)

Carotid dissection presenting as a prolonged cluster-like headache in a patient with episodic cluster headache
por: Elhfnawy, Ahmed Mohamed, et al.
Publicado: (2017)

Neurometabolic correlates of depression and disability in episodic cluster headache
por: Seifert, Christian L., et al.
Publicado: (2010)

Functional magnetic resonance imaging in episodic cluster headache
por: Morelli, Nicola, et al.
Publicado: (2008)

EHMTI-0220. Cortical excitability in episodic cluster headache
por: Cosentino, G, et al.
Publicado: (2014)

Short-term diagnostic stability of probable headache disorders based on the International Classification of Headache Disorders, 3rd edition beta version, in first-visit patients: a multicenter follow-up study
por: Kim, Byung-Su, et al.
Publicado: (2016)

Propofol and Alfentanil in Treatment of a Patient With Episodic Cluster Headache
por: Razavi, Sajjad, et al.
Publicado: (2014)

Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment
por: Dodick, David W, et al.
Publicado: (2020)

Characteristics of Elderly-Onset (≥65 years) Headache Diagnosed Using the International Classification of Headache Disorders, Third Edition Beta Version
por: Song, Tae-Jin, et al.
Publicado: (2016)

Lateralization in cluster headache: a Nordic multicenter study
por: Meyer, Eva Laudon, et al.
Publicado: (2009)

Release of PACAP-38 in episodic cluster headache patients – an exploratory study
por: Tuka, Bernadett, et al.
Publicado: (2016)

COVID-19 vaccination-triggered cluster headache episodes with frequent attacks
por: Brandt, Roemer B, et al.
Publicado: (2022)

Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine
por: Igarashi, Hisaka, et al.
Publicado: (2021)

Pre-attack and pre-episode symptoms in cluster headache: a multicenter cross-sectional study of 327 Chinese patients
por: Li, Ke, et al.
Publicado: (2022)

Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience
por: Altamura, Claudia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d9d28vj5rm0hgs6vidppqr0b01